In vivo inactivation of a deleterious gene has been achieved in a small trial, with excellent clinical results. Interestingly, the delivery and editing system is the same as in previous work on a different disease, and the new therapy required simply changing the guide RNA used to target the Cas9 nuclease. This modular approach could be extended to a number of other genetic diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1051/medsci/2024093 | DOI Listing |
Publication Analysis
Top Keywords
modular approach
8
approach vivo
4
vivo gene
4
gene therapy]
4
therapy] vivo
4
vivo inactivation
4
inactivation deleterious
4
deleterious gene
4
gene achieved
4
achieved small
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!